FDA Approves Takeda’s Eohilia, an Oral Treatment for Eosinophilic Esophagitis
Takeda expects Eohilia single-dose stick packs will be available by the end of February for patients aged 11 years and older with eosinophilic esophagitis.
August 16, 2026
Takeda expects Eohilia single-dose stick packs will be available by the end of February for patients aged 11 years and older with eosinophilic esophagitis.